Oxford Biomedica (OXB) RNS Announcements

Add to Alert list
Date Time Source Announcement
15 Feb 2024 07:00 AM
RNS
Appointment of Joint Corporate Broker
01 Feb 2024 04:48 PM
RNS
Holding(s) in Company
01 Feb 2024 07:00 AM
RNS
Total Voting Rights
31 Jan 2024 07:00 AM
RNS
Block Listing Application
30 Jan 2024 07:00 AM
RNS
Total Voting Rights
29 Jan 2024 08:38 AM
RNS
Completion of Transaction
26 Jan 2024 03:09 PM
RNS
Block listing application
04 Jan 2024 11:49 AM
RNS
Director Declaration
02 Jan 2024 07:00 AM
RNS
Block Listing Return
02 Jan 2024 07:00 AM
RNS
Total Voting Rights
13 Dec 2023 07:00 AM
RNS
2023 AGM Post Meeting Update Statement
07 Dec 2023 07:00 AM
RNS
Business Update
04 Dec 2023 07:00 AM
RNS
Signing of agreement to acquire ABL Europe
01 Dec 2023 07:00 AM
RNS
Total Voting Rights
24 Nov 2023 07:00 AM
RNS
Grant of options
16 Nov 2023 03:32 PM
RNS
PDMR Dealing – Replacement
14 Nov 2023 01:43 PM
RNS
PDMR Dealings
01 Nov 2023 07:00 AM
RNS
Total Voting Rights
24 Oct 2023 06:17 PM
RNS
Holding(s) in Company
24 Oct 2023 05:36 PM
RNS
Holding(s) in Company
16 Oct 2023 07:00 AM
RNS
Holding(s) in Company
13 Oct 2023 07:00 AM
RNS
Holding(s) in Company
11 Oct 2023 11:33 AM
RNS
PDMR Dealings
04 Oct 2023 05:09 PM
RNS
Grant of Options
02 Oct 2023 03:06 PM
RNS
Total Voting Rights
27 Sep 2023 12:03 PM
RNS
PDMR / PCA Dealing
26 Sep 2023 03:47 PM
RNS
PDMR Dealings
22 Sep 2023 11:42 AM
RNS
PDMR Dealings
20 Sep 2023 11:42 AM
RNS
Director Dealings
20 Sep 2023 07:01 AM
RNS
Project Aquarius
20 Sep 2023 07:00 AM
RNS
Interim results
01 Sep 2023 07:00 AM
RNS
Total Voting Rights
22 Aug 2023 07:00 AM
RNS
Expanded agreement with Cabaletta Bio
14 Aug 2023 07:00 AM
RNS
Notice of Interim Results
01 Aug 2023 07:00 AM
RNS
Total Voting Rights
03 Jul 2023 04:31 PM
RNS
PDMR Dealings
03 Jul 2023 07:00 AM
RNS
Oxford Biomedica PLC - Block Listing Return
03 Jul 2023 07:00 AM
RNS
Total Voting Rights
23 Jun 2023 05:32 PM
RNS
Result of AGM
06 Jun 2023 03:59 PM
RNS
Total Voting Rights
15 May 2023 07:00 AM
RNS
Oxford Biomedica launches TetraVecta system
10 May 2023 07:00 AM
RNS
Block listing Application
05 May 2023 07:00 AM
RNS
2023 AGM Notification
02 May 2023 07:00 AM
RNS
Total Voting Rights
28 Apr 2023 07:59 AM
RNS
2022 Annual Report and Accounts
26 Apr 2023 07:00 AM
RNS
Board Appointment
25 Apr 2023 07:00 AM
RNS
Preliminary results for the year ended 31 Dec 2022
25 Apr 2023 07:00 AM
RNS
Preliminary results for the year ended 31 Dec 2022
19 Apr 2023 06:26 PM
RNS
2022 Preliminary results revised date
03 Apr 2023 01:19 PM
RNS
Total Voting Rights

Oxford Biomedica is a company that specialises in cell and gene therapy, and is a leader in the development of gene-based medicines. They work with pharmaceutical and biotechnology companies to develop and manufacture viral vectors, including lentivirus, adeno-associated virus, and adenoviral vectors.

Headquartered in Oxford, Oxford Biomedica has manufacturing facilities in Oxfordshire, UK, Lyon and Strasbourg, France, and near Boston, MA, US.

Oxford Biomedica share price listed in London under the ticker OXB at 2,570p.

UK 100